Inventor · disambiguated record
Steven Jacobs
Also filed as: JACOBS STEVEN · JACOBS STEVEN A · JACOBS STEVEN ALAN
43 granted patents·7 pending applications·409 citations·filing 2009–2024
98Inventor score
Top patents by PatentIndex Score
50 records- 0198US8278419B2Fibronectin type III domain based scaffold compositions, methods and usesJACOBS STEVEN·Filed 2009·Granted Oct 2, 2012·108 cites·1 claims
- 0296US9897612B2Fibronectin type III repeat based protein scaffolds with alternative binding surfacesJANSSEN BIOTECH INC·Filed 2015·Granted Feb 20, 2018·12 cites·7 claims
- 0396US8293482B2Fibronectin type III domain based scaffold compositions, methods and usesJACOBS STEVEN·Filed 2010·Granted Oct 23, 2012·65 cites·2 claims
- 0495US11299534B2CD8A-binding fibronectin type III domainsJANSSEN BIOTECH INC·Filed 2020·Granted Apr 12, 2022·4 cites·20 claims
- 0595US10925932B2Serum albumin-binding fibronectin type III domainsJANSSEN BIOTECH INC·Filed 2017·Granted Feb 23, 2021·8 cites·16 claims
- 0695US10626165B2CD8a-binding fibronectin type III domainsJANSSEN BIOTECH INC·Filed 2017·Granted Apr 21, 2020·14 cites·19 claims
- 0794US11932680B2CD8A-binding fibronectin type III domainsJANSSEN BIOTECH INC·Filed 2022·Granted Mar 19, 2024·2 cites·4 claims
- 0894US10597438B2PD-L1 binding fibronectin type III domainsJANSSEN BIOTECH INC·Filed 2017·Granted Mar 24, 2020·12 cites·17 claims
- 0994US8569227B2Stabilized fibronectin domain compositions, methods and usesJACOBS STEVEN·Filed 2011·Granted Oct 29, 2013·33 cites·4 claims
- 1093US9200273B2Fibronectin type III repeat based protein scaffolds with alternative binding surfacesDIEM MICHAEL·Filed 2012·Granted Dec 1, 2015·20 cites·8 claims
- 1192US8722618B2IL4/IL13 binding repeat proteins and usesJACOBS STEVEN·Filed 2012·Granted May 13, 2014·37 cites·10 claims
- 1291US10611823B2CD137 binding fibronectin type III domainsJANSSEN BIOTECH INC·Filed 2017·Granted Apr 7, 2020·12 cites·11 claims
- 1390US10196446B2Cysteine engineered fibronectin type III domain binding moleculesJANSSEN BIOTECH INC·Filed 2014·Granted Feb 5, 2019·16 cites·3 claims
- 1490US10040842B2Fibronectin type III domain based scaffold compositions, methods and usesJANSSEN BIOTECH INC·Filed 2015·Granted Aug 7, 2018·6 cites·12 claims
- 1590US9695228B2EGFR and c-Met fibronectin type III domain binding moleculesJANSSEN BIOTECH INC·Filed 2013·Granted Jul 4, 2017·15 cites·9 claims
- 1690US9156887B2Non-natural consensus albumin binding domainsJANSSEN BIOTECH INC·Filed 2013·Granted Oct 13, 2015·13 cites·12 claims
- 1789US10662235B2Cysteine engineered fibronectin type III domain binding moleculesJANSSEN BIOTECH INC·Filed 2017·Granted May 26, 2020·4 cites·15 claims
- 1888US10229775B2Magnetocaloric cascade and method for fabricating a magnetocaloric cascadeBASF SE·Filed 2015·Granted Mar 12, 2019·7 cites·15 claims
- 1987US11833190B2Serum albumin-binding fibronectin type III domainsJANSSEN BIOTECH INC·Filed 2021·Granted Dec 5, 2023·1 cites·11 claims
- 2086US10844122B2Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereofJANSSEN BIOTECH INC·Filed 2016·Granted Nov 24, 2020·4 cites·8 claims
- 2184US12291797B2Fibronectin type III domain based scaffold compositions, methods and usesJANSSEN BIOTECH INC·Filed 2022·Granted May 6, 2025·0 cites·4 claims
- 2284US9982253B2Stabilized fibronectin domain compositions, methods and usesJANSSEN BIOTECH INC·Filed 2015·Granted May 29, 2018·4 cites·4 claims
- 2383US12202732B2Aqueous hydrophobic silica dispersionsCABOT CORP·Filed 2024·Granted Jan 21, 2025·0 cites·3 claims
- 2483US9725497B2EGFR and C-Met fibronectin type III domain binding moleculesJANSSEN BIOTECH INC·Filed 2013·Granted Aug 8, 2017·5 cites·13 claims
- 2582US11345739B2CD137 binding fibronectin type III domainsJANSSEN BIOTECH INC·Filed 2020·Granted May 31, 2022·1 cites·20 claims
- 2681US9234029B2Stabilized fibronectin domain compositions, methods and usesJANSSEN BIOTECH INC·Filed 2013·Granted Jan 12, 2016·4 cites·5 claims
- 2778US12258385B2CD137 binding fibronectin type III domainsJANSSEN BIOTECH INC·Filed 2022·Granted Mar 25, 2025·0 cites·9 claims
- 2878US11987501B2Aqueous hydrophobic silica dispersionsCABOT CORP·Filed 2019·Granted May 21, 2024·1 cites·20 claims
- 2974US12304939B2EGFR and C-met fibronectin type III domain binding moleculesJANSSEN BIOTECH INC·Filed 2021·Granted May 20, 2025·0 cites·8 claims
- 3073US11702475B2Cysteine engineered fibronectin type III domain binding moleculesJANSSEN BIOTECH INC·Filed 2021·Granted Jul 18, 2023·0 cites·8 claims
- 3172US11479880B2Fibronectin type III domain based scaffold compositions, methods and usesJANSSEN BIOTECH INC·Filed 2020·Granted Oct 25, 2022·0 cites·11 claims
- 3269US12054534B2Prostate specific membrane antigen binding fibronectin type iii domainsJANSSEN BIOTECH INC·Filed 2020·Granted Aug 6, 2024·0 cites·14 claims
- 3369US9206244B2IL4/IL13 binding repeat proteins and usesJANSSEN BIOTECH INC·Filed 2014·Granted Dec 8, 2015·1 cites·8 claims
- 3468US11072663B2Cysteine engineered fibronectin type III domain binding moleculesJANSSEN BIOTECH INC·Filed 2018·Granted Jul 27, 2021·0 cites·8 claims
- 3568US10654913B2Fibronectin type III domain based scaffold compositions, methods and usesJANSSEN BIOTECH INC·Filed 2018·Granted May 19, 2020·0 cites·11 claims
- 3668US10571472B2Fibronectin type III repeat based protein scaffolds with alternative binding surfacesJANSSEN BIOTECH INC·Filed 2017·Granted Feb 25, 2020·0 cites·5 claims
- 3765US10954284B2EGFR and c-Met fibronectin type III domain binding moleculesJANSSEN BIOTECH INC·Filed 2017·Granted Mar 23, 2021·0 cites·6 claims
- 3864US11447539B2PD-L1 binding fibronectin type III domainsJANSSEN BIOTECH INC·Filed 2020·Granted Sep 20, 2022·0 cites·13 claims
- 3961US10280200B2Non-natural consensus albumin binding domainsJANSSEN BIOTECH INC·Filed 2017·Granted May 7, 2019·0 cites·8 claims
- 4061US8415291B2Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and usesJACOBS STEVEN·Filed 2009·Granted Apr 9, 2013·0 cites·5 claims
- 4161US2015068219A1High Porosity Particulate Beds Structurally Stabilized by EpoxyASTRONAUTICS CORP·Filed 2014·Application pending·0 cites
- 4260US2017159979A1High Porosity Particulate Beds Structurally Stabilized by EpoxyASTRONAUTICS CORP·Filed 2017·Application pending·0 cites
- 4359US12460001B2Proteins comprising CD3 antigen binding domains and uses thereofJANSSEN BIOTECH INC·Filed 2021·Granted Nov 4, 2025·0 cites·50 claims
- 4459US10844111B2Prostate specific membrane antigen binding fibronectin type III domainsJANSSEN BIOTECH INC·Filed 2016·Granted Nov 24, 2020·0 cites·13 claims
- 4558US2020325210A1Cysteine engineered fibronectin type iii domain binding moleculesJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 4655US8617894B2Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and usesCENTOCOR ORTHO BIOTECH INC·Filed 2013·Granted Dec 31, 2013·0 cites·2 claims
- 4751US2017372821A1Magnetocaloric cascade and method for fabricating a magnetocaloric cascadeBASF SE·Filed 2015·Application pending·0 cites
- 4847US2016083436A1Non-Natural Consensus Albumin Binding DomainsJANSSEN BIOTECH INC·Filed 2015·Application pending·0 cites
- 4947US2013019610A1System and method for reverse degradation of a magnetocaloric materialZIMM CARL B·Filed 2012·Application pending·0 cites
- 5047US2011189790A1Methods of Predicting Antibody SolubilityO'NEIL KARYN·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven Jacobs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →